Order Article Reprints
Journal: Pharmaceuticals, 2024
Volume: 17
Number: 1424
Article:
Advice to the FDA to Improve Its Proposed Guidelines to Rationalize Clinical Trials by Restricting Placebo Control, Preventing Low-Powered Studies, and Disallowing Studies Where Bioavailability Is Not Proven
Authors:
by
Sarfaraz K. Niazi
Link:
https://www.mdpi.com/1424-8247/17/11/1424
MDPI offers high quality article reprints with convenient shipping to destinations worldwide. Each reprint features a 270 gsm bright white cover
and 105 gsm premium white paper, bound with two stitches for durability and printed in full color. The cover design is customized to your article
and designed to be complimentary to the journal.